Merck’s first quarter results drew a positive market reaction, reflecting operational resilience despite a 1.6% ...

Keytruda generated sales of $7.21 billion in the first quarter of 2025, rising 6% year over year. Our model estimates for Keytruda suggest a CAGR of 5.4% over the next three years. MRK’s Price ...

Nonetheless, though Keytruda will lose patent exclusivity in 2028, its sales are expected to remain strong until then. Merck is also working on different strategies to drive Keytruda's long-term ...

Trodelvy plus Keytruda improved progression-free survival in PD-L1–positive, advanced TNBC, reducing disease progression or death risk by 35% compared to chemotherapy plus Keytruda. The phase 3 ASCENT ...

Keytruda, the world's biggest-selling prescription medicine, is approved for many types of cancer. “This new information supports changing the current standard of care” to now give Keytruda ...

If you’re prescribed the immunotherapy drug Keytruda to treat your cancer, you may wonder how long the treatment will last. The length of your treatment can vary depending on certain factors.

Keytruda (pembrolizumab) is prescribed to treat melanoma and other conditions by reviving the body’s immune system. Your response to this drug may vary based on your medical history, diagnosis ...

Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma’s under-the-skin version of its blockbuster cancer drug Keytruda.

Akeso designed ivonescimab to have a “tetravalent” structure, in theory giving it better binding to PD-1 and to VEGF. Yang, ... It has gained clearances of regimens involving Keytruda and the ...

In this update, which will be similar in structure to my 2021 article, ... Keytruda itself will lose its main patent protection in the U.S. in 2028 and in the European Union in 2031.

RAHWAY, N.J., October 24, 2024--Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers ...

Keytruda is a prescription drug used to treat certain types of cancer. Learn more about how to know whether Keytruda is working and more.